港股异动 昭衍新药(06127)再涨超4% 本月股价累涨超三成 公司有望受益猴价公允价值收益

Group 1 - The core viewpoint of the article highlights that Zhaoyan New Drug (06127) has seen its stock price increase by over 30% this month, with a current price of 22.14 HKD, reflecting a 4.04% rise at the time of reporting [1] - The price of experimental monkeys has been rising rapidly, currently at approximately 140,000 RMB per monkey, driven by increased demand from preclinical CRO orders and limited supply capacity [1] - According to estimates from Founder Securities, Zhaoyan New Drug could see an increase in fair value of approximately 220 million RMB in 2025, based on projected price increases for experimental monkeys and existing inventory [1]